Literature DB >> 9338943

Skeletal effects of menstrual disturbances in athletes.

K L Bennell1, S A Malcolm, J D Wark, P D Brukner.   

Abstract

This article reviews the skeletal effects and clinical implications of menstrual disturbances in active women. At the lumbar spine, menstrual disturbances are associated with premature bone loss or failure to reach peak bone mass, while appendicular sites are less affected. This suggests that trabecular bone is more sensitive to hormonal stimuli and less responsive to mechanical loading than cortical bone. Although the mechanisms responsible for the detrimental effects of menstrual disturbances are likely to be multifactorial, low circulating levels of oestrogen are thought to be the main cause. The clinical significance of menstrual disturbances depends upon a number of factors, including type of sport, genetic background, body composition and calcium intake. Not all athletes who present with menstrual disturbances will develop osteopenia. Nevertheless, the risk of stress fracture does seem to be increased in athletes with menstrual disturbances and with lower bone density. Whether athletes with menstrual disturbances are at a greater risk for osteoporosis in later life is not yet known. Bone loss can be at least partially reversed, especially with the spontaneous resumption of menses. This may serve to offset any previous increased risk of osteoporosis. Furthermore, other factors, apart from low bone mass, act to determine the likelihood of osteoporotic fractures. Therefore, the clinical significance of menstrual disturbances associated with exercise participation needs to be established for each individual athlete. Bone densitometry may guide the clinician in this respect and assist in the formulation of appropriate management strategies.

Entities:  

Mesh:

Year:  1997        PMID: 9338943     DOI: 10.1111/j.1600-0838.1997.tb00151.x

Source DB:  PubMed          Journal:  Scand J Med Sci Sports        ISSN: 0905-7188            Impact factor:   4.221


  9 in total

Review 1.  Who owns the information? Databases of injuries in professional sport are valuable resources which should not suffer confidentiality restraints.

Authors:  J Orchard
Journal:  Br J Sports Med       Date:  2002-02       Impact factor: 13.800

2.  New criteria for female athlete triad syndrome? As osteoporosis is rare, should osteopenia be among the criteria for defining the female athlete triad syndrome?

Authors:  K M Khan; T Liu-Ambrose; M M Sran; M C Ashe; M G Donaldson; J D Wark
Journal:  Br J Sports Med       Date:  2002-02       Impact factor: 13.800

3.  Banning pregnant netballers--is this the answer?

Authors:  S White
Journal:  Br J Sports Med       Date:  2002-02       Impact factor: 13.800

Review 4.  Is there a role for exercise in the prevention of osteoporotic fractures?

Authors:  O M Rutherford
Journal:  Br J Sports Med       Date:  1999-12       Impact factor: 13.800

Review 5.  Risk factors for stress fractures.

Authors:  K Bennell; G Matheson; W Meeuwisse; P Brukner
Journal:  Sports Med       Date:  1999-08       Impact factor: 11.136

6.  Athletic activity and hormone concentrations in high school female athletes.

Authors:  Edward M Wojtys; Mary L Jannausch; Jennifer L Kreinbrink; Siobán D Harlow; MaryFran R Sowers
Journal:  J Athl Train       Date:  2014-10-20       Impact factor: 2.860

7.  The female athlete triad.

Authors:  Taraneh Gharib Nazem; Kathryn E Ackerman
Journal:  Sports Health       Date:  2012-07       Impact factor: 3.843

8.  Self-reported ballet classes undertaken at age 10-12 years and hip bone mineral density in later life.

Authors:  K M Khan; K L Bennell; J L Hopper; L Flicker; C A Nowson; A J Sherwin; K J Crichton; P R Harcourt; J D Wark
Journal:  Osteoporos Int       Date:  1998       Impact factor: 5.071

9.  Maternal investment, maturational rate of the offspring and mechanical competence of the adult female skeleton.

Authors:  Alison A Macintosh; Jonathan C K Wells; Jay T Stock
Journal:  Evol Med Public Health       Date:  2018-08-16
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.